Compare INVA & BTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVA | BTT |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2000 | 2011 |
| Metric | INVA | BTT |
|---|---|---|
| Price | $23.23 | $22.62 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 811.2K | 83.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 2.22 | N/A |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | $10.62 | ★ N/A |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $21.77 |
| 52 Week High | $25.15 | $23.24 |
| Indicator | INVA | BTT |
|---|---|---|
| Relative Strength Index (RSI) | 54.83 | 44.10 |
| Support Level | $22.21 | $22.48 |
| Resistance Level | $24.22 | $22.79 |
| Average True Range (ATR) | 0.62 | 0.11 |
| MACD | 0.12 | -0.00 |
| Stochastic Oscillator | 47.69 | 37.23 |
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Blackrock Municipal 2030 Target Term Trust is a United States-based closed-end management investment company. The investment objective of the company is to provide current income exempt from regular federal income tax and to return $25.00 per common share to holders of common shares. The trust seeks to achieve its investment objectives by investing a majority of its assets in municipal bonds exempt from U.S. federal income taxes.